Quantcast

Latest pharmaceutical industry Stories

2014-07-11 16:23:25

FALLS CHURCH, Va., July 11, 2014 /PRNewswire/ -- Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI), a leading global pharmaceutical consulting firm, has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds. Due to the complex nature of a multitude of existing as well as newly-discovered active ingredients,...

2014-07-10 23:02:13

In-demand research report “OpportunityAnalyzer: Acne Vulgaris - Opportunity Analysis and Forecasts to 2018” prepared by GlobalData is now available at MarketPublishers.com. According to the study, the six major pharma markets are expected to post an around 4% CAGR through 2018. London, UK (PRWEB) July 10, 2014 Notwithstanding its considerable patient pool across the US and 5EU acne market has remained stagnant over the past few decades, with no new drugs coming into the arena. The...

2014-07-10 23:01:52

According to NAPSRx, the average CNPR pharmaceutical sales rep is working less for that increased income! That is great news for pharmaceutical sales reps, physicians who rely upon these reps and the entire industry in general. CNPR certified Pharmaceutical Sales Reps earn more money with fewer sales calls. (PRWEB) July 10, 2014 Did you know that the average pharmaceutical sales rep earned $103,200 in total compensation in 2013, compared with $97,500 in 2012? This was an estimate made by...

2014-07-10 12:34:06

Visitation to Branded Pharmaceutical Websites Continues to Produce Greatest Lifts RESTON, Va., July 10, 2014 /PRNewswire/ -- comScore, Inc. (NASDAQ: SCOR), a leader in measuring the digital world, today released results from its eighth annual Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry, conducted in partnership with marketing innovation consultancy Evolution Road LLC. Based on comScore's survey data from 163 pharmaceutical studies, these benchmarks...

2014-07-10 10:28:40

Boston Children's Hospital Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS ONE. The study highlights...

2014-07-10 04:21:33

SHANGHAI, July 10, 2014 /PRNewswire/ -- HD Biosciences Co., Ltd. (HDB), the Marshall Institute for Interdisciplinary Research (MIIR) and the Marshall University Joan C. Edwards School of Medicine announced the new partnership to co-develop potential anti-cancer drugs. Under the agreement, the partners will share the costs and risks of discovery and development of new drugs. They will also jointly own intellectual property and commercialization rights of the products developed through...

2014-07-09 23:07:20

Infitrak, Inc and Cedarlane Corporation have announced a sales and distribution agreement to enable Cedarlane to sell and market Infitrak’s qualified packaging solutions. These optimized solutions were specifically engineered to meet or exceed performance needs, and reduce coolant costs and shipping weights. Markham, Ontario, Canada (PRWEB) July 09, 2014 Infitrak, a leader in cold chain management, compliance solutions and monitoring, and Cedarlane Shipping Supplies are pleased to...

2014-07-09 23:06:47

Patented Smart Pill Bottle Company Will Use Capital to Scale the Product and Service New York, NY (PRWEB) July 09, 2014 AdhereTech (AdhereTech.com), a healthcare technology company that makes patented smart pill bottles to improve medication adherence and patient engagement, today announced its initial closing of $1.75 million in Series A financing. The round was led by undisclosed investors with a focus in healthcare. AdhereTech will use the investment to scale its service and meet the...

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-08 23:10:01

GIA announces the release of a comprehensive global report on Pharmaceutical Contract Manufacturing markets. Global market for Pharmaceutical Contract Manufacturing is forecast to reach US$23.4 million by 2020, spurred by pricing pressures and shrinking margins aggravated by patent expiries, regulatory and competitive pressures, and emergence of generics to replace blockbuster drugs nearing patent expiries. San Jose, California (PRWEB) July 08, 2014 Global pharmaceutical contract...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related